Nuclear imaging techniques for cardiac amyloidosis.

Area of Science:

• Cardiology
• Nuclear Medicine
• Medical Imaging

Background:

• Cardiac amyloidosis involves protein misfolding, leading to restrictive cardiomyopathy and heart failure.
• Early and accurate diagnosis is critical for effective clinical management.

Purpose of the Study:

• To review advancements in nuclear imaging for diagnosing and managing cardiac amyloidosis.
• To highlight the importance of these techniques in clinical practice.

Main Methods:

• Cardiac scintigraphy using bone-avid tracers (e.g., 99mTc-PYP, 99mTc-DPD, 99mTc-HMDP).
• Positron Emission Tomography (PET) with amyloid-targeting tracers (e.g., 11C-PiB, 18F-Florbetapir).

Main Results:

• Nuclear imaging is pivotal for diagnosing cardiac amyloidosis.
• Scintigraphy distinguishes transthyretin amyloidosis from light chain amyloidosis.
• PET imaging assesses amyloid burden and monitors disease progression.

Conclusions:

• Advanced nuclear imaging significantly improves cardiac amyloidosis diagnosis and management.
• Accurate differentiation of amyloidosis types is crucial for treatment tailoring.
• Integration into clinical practice enhances patient outcomes and research.